FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA for Ovulation induction: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA was used for Ovulation induction.
Most Reported Side Effects for FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 29 | 27.4% | 0 | 0 |
| Ovarian hyperstimulation syndrome | 27 | 25.5% | 1 | 17 |
| Abdominal distension | 6 | 5.7% | 0 | 4 |
| Ascites | 6 | 5.7% | 0 | 6 |
| Nausea | 6 | 5.7% | 0 | 3 |
| Ovarian cyst | 6 | 5.7% | 0 | 4 |
| Multiple sclerosis relapse | 5 | 4.7% | 0 | 0 |
Other Indications for FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA
In vitro fertilisation (37)
Product used for unknown indication (14)
Infertility (10)
Assisted fertilisation (9)
Other Drugs Used for Ovulation induction
CHORIOGONADOTROPIN ALFA (460)
FOLLITROPIN (249)
CLOMIPHENE (124)
LETROZOLE (122)
MENOTROPINS (107)
FOLLITROPIN BETA (86)
LUTROPIN ALFA (86)
TRIPTORELIN (73)
LEUPROLIDE (64)
GONADOTROPHIN, CHORIONIC (57)